Journal Article Revolutionizing IBD Clinical Trials with Bayesian Approaches Get access Nurulamin M Noor, PhD , Nurulamin M Noor, PhD Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United KingdomDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, Cambridgeshire, United Kingdom Corresponding author: Nurulamin Noor, PhD, Department of Medicine, University of Cambridge School of Clinical Medicine and Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, United Kingdom (email protected). https://orcid.org/0000-0003-3426-6408 Search for other works by this author on: Oxford Academic PubMed Google Scholar Haiyan Zheng, PhD , Haiyan Zheng, PhD Department of Mathematical Sciences, University of Bath, Bath, Somerset, United Kingdom https://orcid.org/0000-0002-3385-2117 Search for other works by this author on: Oxford Academic PubMed Google Scholar David S Robertson, PhD , David S Robertson, PhD Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom https://orcid.org/0000-0001-6207-0416 Search for other works by this author on: Oxford Academic PubMed Google Scholar Siddharth Singh, MD Siddharth Singh, MD Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, CA, United StatesDivision of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, CA, United States https://orcid.org/0000-0002-2640-7269 Search for other works by this author on: Oxford Academic PubMed Google Scholar Inflammatory Bowel Diseases, izaf182, https://doi.org/10.1093/ibd/izaf182 Published: 25 August 2025 Article history Received: 20 July 2025 Editorial decision: 21 July 2025 Published: 25 August 2025
Noor et al. (Wed,) studied this question.